Halozyme Therapeutics, Inc. (NASDAQ: HALO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
HALO QT 63Halozyme Therapeutics, Inc. · NASDAQ
83.23 +1.17%
Short Interest History · Twice monthly
Settlement Date Short Interest Avg Daily Volume Shares Float Short Float % Short Ratio Jul-15-26 13.30M 1.79M 117.25M 11.34% 7.41 Jun-30-26 13.23M 1.73M 117.25M 11.28% 7.67 Jun-15-26 12.95M 1.62M 117.25M 11.04% 7.98 May-29-26 13.64M 1.61M 117.25M 11.64% 8.48 May-15-26 13.39M 1.70M 117.25M 11.42% 7.88 Apr-30-26 14.38M 1.72M 117.25M 12.27% 8.35 Apr-15-26 14.26M 1.74M 117.25M 12.16% 8.21 Mar-31-26 14.05M 1.85M 117.25M 11.98% 7.59 Mar-13-26 13.70M 2.00M 117.25M 11.69% 6.86 Feb-27-26 13.50M 2.06M 117.25M 11.51% 6.56 Feb-13-26 13.80M 2.07M 117.25M 11.77% 6.67 Jan-30-26 13.52M 2.20M 117.25M 11.53% 6.14
▼ Show All 206 Periods
